The role of long non-coding RNAs in cardiovascular diseases: A comprehensive review

Xuena Xie1,2, Meiwen Huang1,2, Shudong Ma2,3

  • 1School of Pharmacy, Faculty of Medicine, Macau University of Science and Technology, Macau SAR, 999078, China.

Non-Coding RNA Research
|February 3, 2025
PubMed

Insights

Long non-coding RNAs (lncRNAs) are crucial in cardiovascular diseases (CVDs). This review explores lncRNA roles in CVDs, highlighting their potential as diagnostic biomarkers and therapeutic targets.

Area of Science:

  • Molecular Biology
  • Genomics
  • Cardiovascular Medicine

Background:

  • Cardiovascular diseases (CVDs) are a major global health burden, with underlying molecular mechanisms incompletely understood.
  • Research traditionally focused on protein-coding genes, but recent genomics advances reveal the significance of long non-coding RNAs (lncRNAs).
  • Altered lncRNA expression is implicated in tissue damage and organ dysfunction, contributing to various diseases.

Purpose of the Study:

  • To comprehensively review the regulatory mechanisms of lncRNAs in cardiovascular health and disease.
  • To discuss the role of lncRNAs in the pathogenesis and progression of specific CVDs.
  • To explore the potential of lncRNAs as therapeutic targets and diagnostic biomarkers for CVDs.

Main Methods:

  • Literature review and synthesis of existing research on lncRNAs and CVDs.
  • Analysis of regulatory mechanisms governing lncRNA expression and function.
  • Examination of lncRNA involvement in diverse cardiovascular conditions.

Main Results:

  • lncRNAs play critical roles in the development and progression of various cardiovascular diseases.
  • Specific lncRNAs are dysregulated in conditions like coronary heart disease, atherosclerosis, heart failure, and cardiomyopathies.
  • lncRNAs exhibit tissue-specific expression patterns influenced by internal and external factors.

Conclusions:

  • lncRNAs are pivotal in cardiovascular pathophysiology and represent promising diagnostic biomarkers.
  • Targeting lncRNAs offers a potential therapeutic strategy for managing cardiovascular diseases.
  • Further research into lncRNA regulatory networks is essential for advancing cardiovascular medicine.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
367
Types of RNA01:20

Types of RNA

Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
5.6K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.0K
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
86